In a patient with moderate chronic urticaria who has not responded to an adequate trial of chlorpheniramine, when and how should systemic steroids be used?

Systemic Steroids in Chronic Urticaria: Not Recommended as Routine Treatment

Systemic steroids are NOT part of the recommended treatment algorithm for chronic urticaria and should only be used as short-term rescue therapy (7-14 days maximum) for severe, intolerable symptoms while transitioning to guideline-directed therapy. 1

The Evidence-Based Treatment Algorithm

The 2022 international urticaria guidelines explicitly outline a 3-step approach that does not include systemic steroids as a treatment line 1:

Step 1: Switch to Second-Generation Antihistamines

• Your patient is on chlorpheniramine, a first-generation antihistamine that is sedating and not recommended 1
• Immediately switch to a second-generation H1-antihistamine (cetirizine, fexofenadine, loratadine, desloratadine, levocetirizine)
• If inadequate control after 2-4 weeks, updose to 4x the standard dose 1

Step 2: Add Omalizumab

• If symptoms remain uncontrolled on quadruple-dose antihistamines after 2-4 weeks (or earlier if intolerable), add omalizumab 300 mg every 4 weeks 1
• Allow up to 6 months for response; can updose to 600 mg every 2 weeks if needed 1
• Achieves complete disease control in ~70% of antihistamine-refractory cases 2

Step 3: Add Cyclosporine

• For patients failing omalizumab, add cyclosporine up to 5 mg/kg body weight 1
• Requires monitoring of blood pressure and renal function every 6 weeks 1

When and How to Use Steroids (If Absolutely Necessary)

Steroids should only be considered in two specific scenarios:

1. Short-term bridge therapy (7-14 days) while initiating guideline-directed treatment if symptoms are severe and intolerable 3, 4

   • Use prednisone or methylprednisolone
   • Rapid taper over 7-14 days maximum
   • This is NOT a treatment line but a rescue measure

2. If long-term steroids are being considered, this indicates treatment failure and the patient should be on cyclosporine instead, which has a steroid-sparing effect 4

Critical Evidence on Steroid Efficacy and Harm

A 2024 systematic review and meta-analysis found that while steroids likely improve urticaria activity, the benefit is context-dependent 5:

• In patients with low-moderate antihistamine response probability (17.5-64%), steroids provide a 14-15% absolute improvement (NNT=7)
• In patients with high antihistamine response probability (95.8%), steroids provide only a 2.2% absolute improvement (NNT=45)
• Steroids increase adverse events by 15% (NNH=9) 5

Common Pitfalls to Avoid

1. Do not continue chlorpheniramine - It's a first-generation antihistamine that causes sedation and is not guideline-recommended 1

2. Do not use prolonged steroids - The risk-benefit profile is poor, and you're delaying effective therapy 1

3. Do not skip omalizumab - It has superior efficacy and safety compared to steroids and should be the second-line agent 1

4. Do not wait too long at each step - If symptoms are intolerable, escalate earlier than 2-4 weeks 1

Your Specific Patient

For your patient who has failed chlorpheniramine:

1. Switch immediately to a second-generation antihistamine at standard dose
2. Updose to 4x if no control after 2-4 weeks
3. Add omalizumab if still uncontrolled after 2-4 weeks on quadruple-dose antihistamines
4. Consider a short 7-14 day steroid course ONLY if symptoms are severe and intolerable while waiting for omalizumab to take effect, but this is optional and not part of the standard algorithm

The guideline is clear: steroids are not a treatment line for chronic urticaria 1.